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Background: The aim of the study was to test the effect of two treatments in cases of acute puerperal metritis
(APM) and clinical metritis (CM).
Methods: Cows with APM and CM (n = 40)) were matched according to plasma fibrinogen levels (Fb) into three
groups. Two negative control groups D (n = 11) and E (n = 17) were composed of healthy cows. The proportion of
animals with APM and CM was similar within the groups. Treatment was started on the 3rd day postpartum (PP).
In group A (n = 15), intramuscular (i.m.) administration of ceftiofur was used for five days in combination with
flunixin for three days. Group B (n = 15) received i.m. administration of ceftiofur for five days followed by two
injections of prostaglandin F2α, with an interval of 8 h, on the 8th day PP. Group C (n = 10) served as a control
group with no treatment. The general health status, body temperature (BT) and vaginal discharge were evaluated
daily. Endometrial biopsies for bacteriology were taken once a week for seven weeks PP. Blood samples for the
analysis of acute phase proteins were collected once a week for six weeks PP. Samples for progesterone analysis
were taken twice a week for seven weeks PP. Fertility performance data were recorded.
Results: The area under the curve of BT was higher in group B than in group D cows (P < 0.05). No differences
were found for vaginal discharge. There were no differences in bacterial growth, start of ovarian activity or serum
amyloid-A or fibrinogen levels among the groups. The haptoglobin concentration was higher in the first and
second weeks PP in group B compared with the other groups (P < 0.05). The number of days open was higher in
group A than in both groups B and D (P < 0.05). The pregnancy rate after the first two services was higher (P < 0.05)
in groups B and D than in groups A and C. The number of services per pregnancy was lower in group B than in
group C (P < 0.05).
Conclusions: Regardless of more severe uterine inflammation found in animals from group B, these cows showed
the same fertility parameters as healthy animals.
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Acute puerperal metritis (APM) and clinical metritis
(CM) occur in the early postpartum (PP) period. They
constitute a widespread problem in dairy farming that
causes high economic losses [1]. Therefore, treatment of
PP uterine inflammation is one of the most frequently
investigated topics in dairy cow health. Regardless of the* Correspondence: tjulia@emu.ee
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distribution, and reproduction in any mediumlarge number of scientific publications devoted to the
treatment of APM and CM, the question of the most
optimal treatment scheme is still open.
During normal uterine involution process after partur-
ition a variety of aerobic and anaerobic bacteria, growing
in the uterine lumen, are removed through a range of
uterine defence mechanisms [2]. These mechanisms are
effective in combination with good preventive measures,
such as ensuring cows’ adequate immune status and the
correct energy balance around calving, together with
good hygiene. Otherwise, following contamination of the
uterine lumen by such pathogens as Arcanobacteriumtral Ltd. This is an Open Access article distributed under the terms of the
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and Escherichia coli can cause inflammation, which can
involve the uterine mucosa alone, or also inflammation of
the uterine wall [2,3]. In some cases is very difficult to dif-
ferentiate APM from CM. Results from previous studies
[3,4] showed that in some cases no pyrexia was found in
cases of APM with severe bacterial infection. So, consid-
ering that APM and CM have the same etiology, and the
difficulty in differentiation between these diseases, they
could both be treated using the same treatment scheme.
So, diagnosis of APM or CM means that inflammation
of uterine wall is caused by pathogens. Treatment of
these uterine inflammations should include using of
intrauterine or parenteral antibiotics. However, the use
of intrauterine antimicrobial therapy does not reduce
the signs of systemic illness caused by APM; although
intrauterine administration produces higher drug con-
centrations in the endometrium, there is little penetra-
tion into the deeper layers of the uterus or the other
reproductive tissues [5,6]. Additionally, the use of intra-
uterine therapy in combination with parenteral antibio-
tics has shown no difference when compared with the
use of parenteral administration alone [7]. Drillich et al.
reported that the use of intramuscular (i.m.) injections
alone can be less expensive for farmers [8]. Therefore,
the use of parenteral antibiotics for the treatment of
APM and CM may be more sensible in practice than
intrauterine administration.
Nonsteroidal anti-inflammatory drugs (NSAID) and
prostaglandin (PG) F2α are often used in addition to
antibiotics. However, the results of studies in which the
effects of these drugs have been tested are not consistent
[9,10]. The results of studies concerning the use of
PGF2α alone show the same problem. Some investiga-
tions showed a clear positive effect of PGF2α on fertility
parameters [11-13], while others found no effect of
PGF2α on fertility parameters [14-17].
The objective of this study was to compare systemic
antibiotic treatment in combination with either flunixin-
meglumine (an NSAID) or PGF2α for the treatment
of APM and CM. The effect of these combinations on
clinical and inflammatory parameters and fertility traits
on a commercial dairy herd were investigated.
Materials and methods
Study was performed according to approval of an ethics
committee of animal experiments of Estonian Ministery
of Agriculture from 04.09.2007 ref no. 7.2-11/6940 - 1.
Farm and animals
The study was conducted from September 2007 to
February 2008 on a loose-housing commercial dairy farm
with 600 cows. All cows were fed the same diet in the
form of a total mixed ration (TMR). The TMR consistedof a mixture of grass silage and concentrate. The cows
were milked three times a day using a 2 × 20 parallel
milking parlour.
Multiparous late pregnant Estonian Holstein Friesian
cows (n = 68) with mean milk production during the
previous lactation of 10,233 kg energy-corrected milk,
and which were expected to calve during the following
two months, were used for the study.
Diagnosis and treatment
Animals with clinical mastitis, arthritis, hoof problems
and other clinical diseases other than APM and CM
were excluded from the study. The diagnosis of APM
and CM was made on the 3rd day PP using vaginal and
rectal examination and body temperature measurements.
Clinical metritis was defined if an atonic uterus with
purulent or mucopurulent vaginal discharge was found,
without changes in general health condition. A diagnosis
of APM was confirmed when increased body temperature
(≥ 39.5°C), anorexia, an enlarged and atonic uterus and
odiferous vaginal discharge with the presence of pus were
found [2,18]. To ensure minimal variation of the initial
response to inflammation of the uterus among the treat-
ment groups, stratified randomisation, on the basis of the
plasma fibrinogen (Fb) measurements on day 3 PP, was
used. The cows were divided into subgroups with min-
imal variation in fibrinogen concentration (for example, a
subgroup with concentrations between 5.1 g/l and 6.0 g/l
was used). Animals in each subgroup were assigned ran-
domly to the three experimental groups. Treatment of the
animals was started on the 3rd day PP. Group A (n= 15)
was treated by s.c. injection of 1 mg/kg Ceftiofur (Exenell
RTUW, Pharmacia Animal Health) for five days, in com-
bination with simultaneous injections of 1.1 mg/kg Flu-
nixin (FinadyneW vet., Schering-Plough Animal Health)
for the first three days. Animals in group B (n= 15) were
treated by injection of 1 mg/kg Ceftiofur (Exenell RTUW,
Pharmacia Animal Health) for five days followed by two
injections of 25 mg PGF2α (Dinoprost; Dinolytic
W, Pfizer
Animal Health), with an interval of 8 h, on the 8th day
PP (treatment scheme described by Melendez et al. [13]).
Group C (n= 10) served as a positive control group with
no treatment.
Animals with a body temperature of < 39.5°C, tonic
uterus, clear or some blood containing (normal lochia)
vaginal discharge without any pus, and absence of anor-
exia, were diagnosed as healthy cows and incorporated
negative control group D (n = 11). An additional negative
control group, E (n = 17), was formed to allow examin-
ation of the normal Fb level in healthy cows.
Clinical examination
The cows were observed daily for morning body temp-
erature (BT) and health problems. Body temperature
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tical analysis was performed from day 3 PP. Temperature
measurements were made during the first two weeks PP.
Health problems were recorded starting from two weeks
before parturition until the end of the experimental period
at seven weeks PP. Evaluation of the presence and charac-
ter of vaginal discharge on the vulva, perineum, or tail was
assessed daily for each animal for seven weeks PP. The
appearance of vaginal discharge was scored as according
to Bekana et al. [19] as follows: 0 =no discharge; 1= clear
mucus; 2 =mucus with the presence of pus; 3 = viscous
purulent material; 4 = viscous haemopurulent discharge;
5 =watery mucohaemorrhagic malodorous secretion.
Bacteriological sampling and examination of the uterus
Biopsies from the uterine endometrium were collected
from animals with CM and APM (groups A, B and C)
once a week over a period of seven weeks. If two se-
quential samples from the same animal were determined
to be bacteriologically negative, assessed as a uterus clear
of bacteria, collection of biopsies from this animal
stopped. The first biopsy was taken between days 3 and
7 PP. Samples were collected according to the methods
described by Bekana et al. [19] and Kask et al. [20]. At
the start of sampling the cow`s tail was secured, faeces
were removed from the rectum, and the perineal region
and vulva were thoroughly washed and disinfected. The
vulva lips were parted to introduce an externally sterile
protective stainless steel tube. The instrument was
advanced into the vagina and fixed in the external open-
ing of the cervix. A sterile long guarded culture instru-
ment was advanced into the uterus by cervical
manipulation, and opened. A milled cavity with a shar-
pened edge, forming a curette about 2 cm in length,
0.5 cm from the rounded tip, was located with the fore-
finger of the hand in the rectum and biopsy was
obtained from the endometrium. The biopsies were
placed immediately in 10 ml of a freshly prepared thio-
glycollate medium (LAB M, Bury, England) for transpor-
tation to the laboratory. Aliquots of 0.01 ml of each
sample (in the thioglycollate medium) were spread on
Columbia blood agar plates containing 5% bovine blood.
The plates were cultivated aerobically and anaerobically
and examined after 24 and 72 h respectively. Identi-
fications were made according to Bergey’s Manual of
Systematic Bacteriology [21]. To determine the species
of the isolates, BBL CrystalTM (Becton, Dickinson and
Company, Maryland, USA) miniaturized biochemical
test systems (Gram positive, Enteric/nonfermenters and
Anaerobe ID kits (BD BBL CristalTM Identification
Systems)) were used. The intensity of bacterial growth
on the plates was interpreted as follows: 0 = no bacteria
isolated, 1 =mild growth (1–20 isolated colonies per
10 μl of cultivated material), 2 =moderate growth (21–40 isolated colonies per 10 μl of cultivated material),
3 = heavy growth (≥41 isolated colonies per 10 μl of cul-
tivated material).
Blood samples
Blood samples for analysis of acute phase proteins (APP)
(serum amyloid-A (SAA) and haptoglobin (Hp)) were
taken from coccygeal vessels using heparinized venoject
glass tubes (Terumo Europe N. V. Leuven, Belgium).
Collection was started nine days before parturition and
was performed once before parturition, and once a week
for six weeks after parturition. After immediate centrifu-
gation, about 5 ml of plasma was removed and stored
at −18°C until analysis. Whole blood for Fb analyses
was taken once a week during the entire experimental
period, starting on the 3rd day PP.
For the determination of progesterone (P4), plasma
samples were collected twice a week. Collection was
started from day 10 PP and continued until day 55 PP.
Plasma was stored at −18°C until analysis.
Methods of analysis of APP
The fibrinogen concentration in plasma was measured
by the heat precipitation method [22]. Microhaematocrit
tubes were filled with EDTA whole blood and sealed at
one end. After centrifugation for 3 min at 6.000 r/min,
the tubes were placed in a water-bath at 56.3°C for
3 min. The plasma Fb concentration (g/l) was measured
after a second centrifugation for 3 min, by calculating
the percentage of the precipitated Fb column relative to
the length of the plasma column. Plasma Hp was deter-
mined using the haemoglobin binding assay described
by Makimura and Suzuki [23], with the modification of
tetramethylbenzidine (0.06 mg/ml) used as a chromogen
[24]. Pooled and lyophilized aliquots of bovine acute
phase serum were used to create standard curves. To
calibrate the assay, a bovine plasma sample with a known
Hp concentration provided by the European Commission
Concerted Action Project (number QLK5-CT-1999-
0153) was used. The range of the standard curve
was 0.04–1.16 g/l. If a sample’s Hp concentration was
higher, the sample was diluted with isotonic saline and
re-assayed. The intra- and inter-assay coefficients of vari-
ation were <12% and <11% respectively. Concentrations
of serum amyloid A (SAA) in plasma were measured
with a commercially available ELISA kit (Phase SAA kit,
Tridelta Development Ltd.) according to the manufac-
turer’s instructions. The detection limit of the assay for
bovine samples is 0.3 mg/l. The intra- and inter-assay
coefficients of variation were <7% and <14% respectively.
P4 analysis
Plasma P4 was determined with a commercially available
ELISA kit (EIA-1561, DRG Instruments GmbH, Germany)





























Figure 1 Mean (±SEM) daily body temperature of cows
treated with a combination of parenteral antibiotic and NSAID
(group A) and with a combination of parenteral administration
of antibiotic and PGF2α (group B), in comparison with the
non-treated control group (group C) and healthy cows
(group D).
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assay precision at P4 concentrations of 0.28 and 5.2 ng/ml
were 6.76 and 7.76%, respectively. The inter-assay preci-
sion at P4 concentrations of 0.28 and 4.9 ng/ml were 7.28
and 2.78%, respectively.
The plasma P4 concentration was used to determine
the number of days to the first luteal response PP,
defined as the first two consecutive measurements of P4
concentrations > 1 ng/ml.
Fertility analysis
For evaluation of fertility performance, the interval from
calving to the first insemination (days to first service,
DFS), first service conception rate (FSCR,%), two service
(first and second) conception rate (TSCR,%), interval
from calving to successful insemination (days open, DO)
and number of services per pregnancy (NSP) were
recorded for all cows.
Statistical analyses
Linear random-intercept models were used to explore
differences in APP concentrations between the treatment
groups. Treatment group, sampling time (week), their
interaction and diagnosis (APM or CM) were included
as fixed factors in the initial models. Diagnosis was
not included in the final models because it was non-
significant. The cow was included as a random factor.
Isotropic spatial exponential correlation structures were
used to model serial correlations of repeated measure-
ments within cows. Logarithmic transformation of SAA
and inverse-root transformation for Hp were used. Dif-
ferences in bacterial counts and vaginal discharge among
groups were tested using generalized linear mixed mod-
els in which a Poisson distribution was used for the
response variables. The cow was included as a random
factor. Linear time (weeks) as a continuous variable, and
time interactions with treatment group and diagnosis
(APM or CM), were included as fixed factors. Overall
time trend differences between challenges were tested
with an F-test. Isotropic spatial exponential correlation
structures were used for modelling serial correlations of
repeated measurements within cows in both mixed
models. The nlme-package [25] with statistical software
R 2.5.0 [26] was used for fitting linear random-intercept
models, and generalized linear mixed models were fitted
using the GLIMMIX procedure [27] software with the
SAS/STAT 9.1 (SAS Institute Inc., Cary, NC, USA).
For comparing differences in rectal temperature, the
area under the curve (AUC) was calculated for each
cow. Analysis of variance, followed by the Bonfferoni
correction, was used to compare mean AUC values
among the treatment groups. Logistic regression was
used to evaluate differences among treatment groups in
days to the first luteal response (before 50 days PP orafter 50 days PP), first service conception (pregnant
or not) and second service conception results. Poisson
regression was used to evaluate group differences in
NSP, and linear regression was used to evaluate group
differences in DO after logarithmic transformation of
DO. These analyses were made using STATA 10.0 (Stata
Corporation, Texas, USA) software. Data are presented
as means ± SEM.
Power analyses of treatment effect to fertility para-
meters were made retrospectively.
Results
One animal from group B was culled from the herd
before the end of the sampling period because of polyar-
thritis and was excluded from the study. There was
a small variation in the proportion of animals with diag-
nosed APM within groups (6 of 15 (40%), 5 of
14 (35.7%) and 4 of 10 (40%) in groups A, B and C,
respectively). The other animals from groups A, B and C
showed signs of CM.
Clinical parameters
The raw data of daily body temperature is presented in
Figure 1. The area under the mean BT curve (AUC) was
highest in group B (AUC=775.49 ± 1.22). It was signifi-
cantly higher than in groups D (AUC= 770.85 ± 0.85,
P = 0.04) and showed the trend to be higher than in
group A (AUC=771.41 ± 0.96, P = 0.056). The area
under the BT curve in group C was similar to that in
group A (AUC= 771.31 ± 1.74), but no differences were
found in comparison with the other groups.
The mean score for vaginal discharge in animals with
a diagnosis of APM at the beginning of the study
was higher than in animals with CM (P < 0.001). The
decrease in the vaginal discharge score throughout the
study period did not differ between cows with APM and















Figure 3 Mean (±SEM) score of bacterial growth in cows
treated with a combination of parenteral antibiotic and NSAID
(group A) and with a combination of parenteral administration
of antibiotic and PGF2α (group B), in comparison with the
non-treated control group (group C) and healthy cows. The
number of bacterial colonies was scored as follows: 0 =no bacteria
isolated, 1 =mild growth (1–20 isolated colonies), 2 =moderate growth
(21–40 isolated colonies), 3 =heavy growth (≥41 isolated colonies).
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groups in vaginal discharge were found (Figure 2).
Bacteriological examination
The results for bacteriological growth are presented in
Figure 3. A total of 201 biopsy specimens were collected,
of which 101 were positive for bacteria; the remaining
100 biopsy samples were found to be bacteriologically
negative. The highest number of positive samples was
found in group B (49 of the total of 101 positive sam-
ples). Nine consistently negative animals out of the 40 in
groups A, B and C were found. From the 101 positive
samples, 15 showed mixed infections: two samples from
group A, 10 from group B, and three samples from
group C. The most frequent isolates in the positive
samples were Bacteroides spp. (30.7%), Corynebacterium
spp (21.8%). and A. pyogenes (10%). The number of posi-
tive samples and the intensity of bacterial growth
decreased with every week PP (P < 0.001 and P < 0.001,
respectively). Animals with an APM diagnosis showed
more intensive bacterial growth in all groups (P = 0.04).
However, the number of positive samples, intensity of
bacterial growth and their time trends did not differ
between groups.
Acute phase proteins
The maximal levels of SAA were seen in all groups dur-
ing the 1st week after parturition (P < 0.001 in all groups;
Figure 4a). The differences in levels among groups, con-












Figure 2 Mean (±SEM) score for vaginal discharge of cows
treated with a combination of parenteral antibiotic and NSAID
(group A) and with a combination of parenteral administration
of antibiotic and PGF2α (group B), in comparison with the
non-treated control group (group C) and healthy cows
(group D). Vaginal discharge was scored as follows: 5 =watery
mucohaemorrhagic malodorous secretion; 4 = viscous
haemopurulent discharge; 3 = viscous purulent material; 2 =mucus
with the presence of pus; 1 = clear mucus; 0 = no discharge.The maximal levels of Hp were also seen in all groups
during the 1st week after parturition (Figure 4b). Hp
levels in group B in the 1st week PP were higher than in
groups A and D (P = 0.047 and 0.032, respectively). The
levels in group B also remained higher in the 2nd week,
when compared with groups A and C (P = 0.013 and
0.011, respectively).
Figure 5 shows the change in the group means for Fb
levels. There was no difference between the groups in
the change of levels from the first Fb values.
There was no difference in the levels of APP between
animals with APM and those with CM.Progesterone
One animal out of 51 was culled from the herd because
of polyarthritis before the end of the sampling period
and was excluded from the analysis of the start of ovar-
ian activity. More than half of the animals (29 out of 50)
showed the start of ovarian activity (first luteal phase
postpartum) during the first 50 days PP. The majority of
animals in groups C and D showed an increase in pro-
gesterone of above 1 ng/ml: 70% (7 of 10) and 63% (7 of
11), respectively. Luteal activity was seen in fewer
animals from groups A and B during the first 50 days
PP: 53% (8 of 15) and 50% (7 of 14), respectively. No
statistical difference between the groups was found with
regard to the start of ovarian activity.Fertility parameters
Of the total of 51 cows, fertility data were obtained from
39. The data for 12 animals (two cows in group A, seven
in group B, two in group C, and one in group D) were
absent because the cows had been culled owing to health



























Figure 4 Mean (±SEM) concentrations of serum amyloid A
(a) and haptoglobin (b) in cows treated with a combination
of parenteral antibiotic and NSAIDs (group A) and with a
combination of parenteral administration of antibiotic and
PGF2α (group B), in comparison with the non-treated control
group (group C) and healthy cows (group D).
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pneumonia and other diseases) during the period between
5 weeks and 6 months PP.
Table 1 provides a summary of the parameters of repro-















Figure 5 Mean (±SEM) concentrations of fibrinogen in cows
treated with a combination of parenteral antibiotic and NSAIDs
(group A) and with a combination of parenteral administration
of antibiotic and PGF2α (group B), in comparison with the
non-treated control group (group C) and healthy cows
(group E).longer period of DO than those in groups B and D
(P=0.016 and 0.039, respectively). There was no differ-
ence among the groups in the number of days to first ser-
vice and the first service conception rate. The two-service
conception rate was significantly higher in group D than
in both groups A and C (P= 0.049 and 0.035, respect-
ively). It was not possible to perform analysis of the TSCR
in group B using logistic regression because of a 100%
pregnancy rate. The number of services per pregnancy
was detected as minimal in group B in comparison with
group C (P= 0.027). It was also smaller in group B than
in groups A and D, this difference was close to signifi-
cance (P= 0.054 and P=0.075, respectively). Animals
diagnosed with APM showed the same DFS, DO, FSCR,
TSCR, and NCP as animals with CM.
The results of retrospective power analyses based
on the observed differences of FSCR, TSCR and DO
between treatment groups showed that the power of the
experiment was 40-50%. To achieve 80% power the size
of each group should be at least 22 animals.
Discussion
The retrospective analysis of optimal sample size and
power analysis showed that sample size of our study is
not enough for good power of the study. The treatment
studies are usually expensive and work and time
requested. Granted of afore mentioned reasons, we
unfortunately, could not involve more animals. However,
we got a statistically significant difference between treat-
ment groups with P-value less than 0.05. Differences
between groups were so considerable, that significant
differences were found even with the small group sizes
used in this experiment. The probability of Type I error
(getting of false positive result) is several times less,
than probability of Type II error (getting of false nega-
tive result) [28], and the possibility of this error was mini-
mized as statistically significant P-values were achieved.
So, regardless of small sample size used in the study, the
results of the study can be regarded as reliable.
The first purpose in the treatment of APM and CM is
to support the cow’s wellbeing and reduce the period of
depression and loss of appetite. Reducing the clinical
signs of disease (normalization of BT and vaginal dis-
charge), followed by a decrease in the systemic inflam-
matory reaction, and elimination of bacteria from the
uterine lumen, are the physiological indicators of
the disappearance of these diseases. Non-steroidal anti-
inflammatory drugs, due to their antipyrectic and anti-
inflammatory effects, should reduce the clinical signs
and inflammatory parameters that accompany APM and
CM, as well as signs of intoxication. It is especially
important in the case of severe cases of APM and toxifi-
cation due to lipopolysaccharides from bacteria (E.coli
and others). These conditions may be fatal if not treated.
Table 1 Fertility parameters of cows treated with a combination of parenteral antibiotic and NSAID (group A) and with
a combination of parenteral administration of antibiotic and PGF2α (group B) in comparison with the non-treated








rate (%; number of
pregnant animals)
Two services conception




A (n = 13) 82.3 ± 4.0 a 170.4 ± 20.8 a 23; 3/13 a 46; 6/13 a 2.85 ± 0.42 ab
B (n = 8) 98.6 ± 13.6 a 120.6 ± 21.9 b 50; 4/8 a 100; 8/8 1.5 ± 0.19 a
C (n = 8) 76.6 ± 5.0 a 157.0 ± 20.3 ab 37; 3/8 a 37; 3/8 a 3.25 ± 0.88 b
D (n = 10) 85.8 ± 5.9 a 115.3 ± 15.3 b 30; 3/10 a 90; 9/10 b 1.9 ± 0.28 ab
a,b Groups with different superscripts within the column differ significantly (P < 0.05).
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not help to decrease the BT more rapidly than occurred
in non-treated animals. The process of normalisation of
vaginal discharge and decrease of APP levels in the
group treated with flunixin was not optimal, but it
also was not worse than in the non-treated group. The
number of bacteriologically positive samples from uter-
ine biopsy, intensity of bacterial growth and their time
trends, and the start of ovarian activity did not differ
among the groups. These results are in agreement with a
study by Drillich et al. [10], who evaluated the effects
of a single administration of flunixinmeglumine in
addition to systemic antibiotic treatment in cows with
acute puerperal metritis and did not detect any effect of
flunixin on clinical cure.
The same study [10] showed the absence of an effect
of flunixin on reproductive performance compared to
another treated group. In the study of Amiridis et al. [9],
animals with puerperal metritis treated by flunixin
meglumine, in addition to systematic antimicrobial treat-
ment, showed more rapid uterine involution and start of
ovarian activity than controls, which is not in agreement
with the present study. In the current study animals
treated by flunixin showed the same interval from calv-
ing to the first insemination as other animals. The start
of ovarian activity also did not differ between groups.
The number of DO in our study was significantly higher
in treatment group A in comparison with treatment
group B and healthy animals. The pregnancy rate after
the first two services, and the number of services per
pregnancy in group A, also did not differ from those of
the positive control group C. The absence of a positive
effect of flunixin administrated in the early PP on fertil-
ity could be explained by no effect of flunixin on the
ovaries and a weak effect on the uterus, in contrast with
exogenous PGF2α. administrated after a decrease in
endogenic PG levels. It is known that as long as the
PGF2α release dominates, as occurs during PP uterine
inflammation, ovulation does not occur. When the PG
metabolite levels have returned to baseline, ovulation
can occur [29]. In the study of Königsson et al. [30], the
early (3–6 days PP) flunixin treatment, when the releaseof PG is high, also suppressed levels of PG metabolites
during the treatment period of cows with PP uterine
inflammation. But this suppression was not complete,
and not so severe, as in case of administration of flu-
nixin at the end of the second week PP. Lindell et al.
[31] and Madej et al. [32], however, showed a significant
negative correlation between the duration of PG release
and uterine involution. Guiltbault et al. [33], in contrast,
did not detect a negative effect of flunixin meglumine on
uterine involution. In the present study, the number of
DFS was the same in all groups, which indicated simul-
taneous uterine involution in all groups. Therefore:
healthy, diseased and treated, and diseased and non-
treated animals needed the same time to first insemin-
ation. These results are in agreement with studies by
Gautam et al. [34] and Barlund at al. [35], in which ani-
mals with clinical uterine inflammation did not need
more time to first insemination than healthy cows. The
start of ovarian activity in the present study was also the
same in all experimental groups.
It is interesting that animals in non-treated group C
did not show a larger number of DO than healthy ani-
mals. Dolezel et al. [36] reported that the probability of
conceiving from the first insemination was the same in
animals with AMP and animals with clinically normal
vaginal discharge. Similar results were obtained in the
current study, where the FSCR was the same in all
groups. Therefore, the probability of becoming pregnant
after the first insemination was the same in the group
treated by flunixin and the group treated by PGF2α, as
well as in healthy and untreated animals. Hendricks et al.
[16] also showed that treatment using PGF2α did not
alter the probability of pregnancy at first insemination.
However, the TSCR in the present study was highest
in the group treated by PGF2α in addition to parenteral
antibiotics, and in the healthy control group. Animals
from group B showed the same positive result for NSP
as control group D. These results are in agreement with
some previous studies in which the mean number of
services per pregnancy was lower in healthy animals
[34,35], which means that cows from group B in the present
study probably recovered from uterine inflammation. It is
Jeremejeva et al. Acta Veterinaria Scandinavica 2012, 54:45 Page 8 of 9
http://www.actavetscand.com/content/54/1/45known that prostaglandins enhance uterine defence
mechanisms, help to promote uterine contractility, con-
tribute to uterine involution and help to shorten periods
of bacterial infection [11-13]. Hirsbrunner et al. [15] in
their study, however, did not detect any significant effect
on the fertility parameters measured (DFS, DO, NSP)
using PGF2α in dairy cows in the PP period. In addition,
Mejia and Lacau-Mengido [17], who used a PGF2α
analogue for treatment of endometritis, detected a nega-
tive effect of PGF2α on the DFS and pregnancy rate by
day 90 PP in multiparous cows.
The only negative effect of PGF2α in the present study
was found for inflammatory parameters and the clinical
conditions of the animals (the highest BT and Hp con-
centration in the early PP period). Use of PGF2α, in
combination with systemic antibiotic for the treatment
of APM, in a study by Jeremejeva et al. [37], also did not
improve the condition of the uterus during the late PP
period. Bonnet et al. [12], in contrast, reported that
treating cows with PGF2α reduced the incidence of vagi-
nal discharge, decreased the diameter of the uterine
horns, reduced inflammation and fibrosis in the endo-
metrium and minimized the possibility of isolation of
Actinomyces pyogenes from endometrial biopsy samples
taken on the 40th day PP. In the present study, vaginal
discharge, intensity of bacterial growth and the start of
ovarian activity in animals treated by PGF2α were not
better than in the other groups.
Choosing a treatment strategy for APM and CM must
be based on the animal welfare and economic aspects. It
is important not to over-diagnose PP uterine inflamma-
tions and is possible that in the case of less severe cases
of CM PGF2α alone should be used.Conclusions
Treatment of APM and CM using NSAID in addition to
parenteral antibiotic did not improve clinical cure, in-
flammatory parameters or elimination of bacteria from
the uterus. Animals from the group given NSAID
showed the same fertility parameters (length of interval
from calving to first insemination, first service concep-
tion rate, conception rate after two services, interval
from calving to successful insemination and number of
services per pregnancy) as non-treated animals. Regard-
less of more severe inflammation that was detected in
animals from the group treated by parenteral adminis-
tration of antibiotic with PGF2α (the highest body
temperature and concentration of Hp), they showed the
same fertility parameters as healthy animals.Competing interests
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